Use of Captopril as Early Therapy for Renal Scleroderma: A Prospective Study
- 1 January 1985
- journal article
- research article
- Published by Elsevier
- Vol. 60 (11) , 763-771
- https://doi.org/10.1016/s0025-6196(12)60418-2
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Trial of platelet‐inhibiting drug in scleroderma double‐blind study with dipyridamole and aspirinArthritis & Rheumatism, 1984
- Hypertension and Renal Failure (Scleroderma Renal Crisis) in Progressive Systemic SclerosisMedicine, 1983
- OBJECTIVE EVALUATION OF HAND FUNCTION IN SCLERODERMAN PATIENTS TO ASSESS EFFECTIVENESS OF PHYSICAL THERAPYRheumatology, 1983
- Variable response to oral angiotensin‐converting‐enzyme blockade in hypertensive scleroderma patientsArthritis & Rheumatism, 1982
- CaptoprilNew England Journal of Medicine, 1982
- Clinical Course of Patients with Scleroderma Renal Crisis Treated with CaptoprilNephron, 1981
- IMMUNE-COMPLEX GLOMERULOPATHY IN PATIENTS TREATED WITH CAPTOPRILThe Lancet, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Reversal of Vascular and Renal Crises of Scleroderma by Oral Angiotensin-Converting-Enzyme BlockadeNew England Journal of Medicine, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978